Pharma Mar Q1 Net Income EUR 22 Million; Revenue EUR 53 Million

• (PLX AI) - Pharma Mar says good performance of the oncology business led to recurring revenues (sales plus royalties), growing by 7% in the first three months of the year to EUR 46 million.
• • Q1 net income EUR 22 million
• • Q1 EBITDA EUR 20.6 million
• • Q1 total revenue EUR 53 million